Concerning the continuation of the Colorado licensing of controlled substances act, and, in connection therewith, implementing the recommendations contained in the 2025 sunset report by the department of regulatory agencies.
HB26-1214 continues the Colorado Licensing of Controlled Substances Act, which is scheduled to repeal on September 1, 2026, and extends it to September 1, 2041. The bill is a sunset reauthorization measure from the Department of Regulatory Agencies’ 2025 sunset review, and it updates the statutory framework governing the Behavioral Health Administration’s licensing, record-keeping, and central registry functions for substance use disorder treatment programs that administer or dispense controlled substances.
The bill modernizes several definitions and terms in the controlled substances treatment statutes. It replaces older references to “detoxification treatment,” “maintenance treatment,” and “withdrawal treatment” with the broader term “withdrawal management,” adds a new definition for “medically managed treatment,” and revises the definition of “substance use disorder” to reflect current clinical language. It also updates identity-verification provisions and central registry references to focus on opioid treatment programs and opioid use disorder, and removes obsolete defined terms that are no longer used in the act.
The bill primarily affects Title 27, Article 80 of the Colorado Revised Statutes, extending the repeal date for the licensing and registry functions of the Behavioral Health Administration from 2026 to 2041 and revising the statutory definitions and rulemaking authority tied to controlled-substance treatment programs. It also makes conforming changes in related statutes that reference those definitions, including provisions involving facility registration, contraband, and THC-related definitions. In practical terms, the bill preserves the state licensing framework for treatment programs that use controlled substances in care, while aligning the law with current behavioral health and addiction-treatment terminology.
The overall sentiment appears supportive and routine, consistent with a sunset continuation bill that implements agency recommendations rather than creating a new policy direction. The bill passed through the legislative process and was signed by the Governor, suggesting broad acceptance of the need to keep the regulatory program in place. No committee transcripts or recorded votes were provided, but the absence of documented controversy and the nature of the measure indicate a generally favorable reception.
The main points of potential contention are likely to have centered on the terminology changes and the scope of the regulatory program, especially the shift from older treatment labels to “withdrawal management” and “medically managed treatment,” and the move to more specific opioid-related language in the identity-verification and registry provisions. Those changes may matter to treatment providers, behavioral health facilities, and regulators because they affect how programs are described and administered in statute. However, no specific objections, amendments, or divided votes were provided in the record.